Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia
Article in Diabetes Obesity and Metabolism (April 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Diabetes Obesity and Metabolism (April 2024)
Article in JAMA Internal Medicine (April 2024)
Article in Diabetes Obesity and Metabolism (April 2024)